Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, +23

Journal of Clinical Oncology

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, +18

Journal of Clinical Oncology

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

Alena Gros, Paul F. Robbins, Xin Yao, +13

Journal of Clinical Investigation

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Paul F. Robbins, Yong‐Chen Lu, Mona El‐Gamil, +9

Nature Medicine

Tumor BiologyTumor-reactive T CellsCancer ImmunosurveillanceTumor HeterogeneityMedicine +11

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, +15

Clinical Cancer Research

Immunogenicity of somatic mutations in human gastrointestinal cancers

Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, +10

Science

Cancer ImmunosurveillanceSomatic VariantSomatic MutationsGastrointestinal OncologyHuman Immune System +13

Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer

Sri Krishna, Frank J. Lowery, Amy R. Copeland, +19

Science

Cutting Edge: Persistence of Transferred Lymphocyte Clonotypes Correlates with Cancer Regression in Patients Receiving Cell Transfer Therapy

Paul F. Robbins, Mark E. Dudley, John R. Wunderlich, +6

The Journal of Immunology

Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers

Frank J. Lowery, Sri Krishna, Rami Yossef, +39

Science

Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

Yong‐Chen Lu, Xin Yao, Jessica S. Crystal, +9

Clinical Cancer Research